Rheumatoid arthritis drug shows promise against COVID-19, study finds
A drug against rheumatoid arthritis called baricitinib could potentially be repurposed to treat patients with COVID-19, according to a study […]
» Read moreHome »
Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into […] (HealthDay)—A magnetic resonance imaging (MRI)-guided treat-to-target strategy is not associated with improved disease activity remission rates for patients with rheumatoid […] (HealthDay)—Different from osteoarthritis, which is the wear-and-tear breakdown of joint cartilage experienced over time, rheumatoid arthritis, or RA, is an […] Rheumatoid arthritis (RA) affects over 1.3 million Americans. The hands, wrists, and knees are the areas commonly affected. In this […] (HealthDay)—High adherence to the Mediterranean diet score is tied to lower risk of rheumatoid arthritis (RA) in some populations, according […] Rheumatoid arthritis (RA) in the elbow can be very uncomfortable, and it may affect daily tasks, such as reaching for […] An international research group led by Charité – Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis. […]
New clues on tissue damage identified in rheumatoid arthritis and lupus
MRI-guided Tx strategy not superior for rheumatoid arthritis
Exercising with rheumatoid arthritis
Rheumatoid arthritis in the wrist: Symptoms, treatment, and exercises
Mediterranean diet tied to lower risk of rheumatoid arthritis
Rheumatoid arthritis: How does it affect the elbow?
Prospect of a new treatment for rheumatoid arthritis
